Nicolet Advisory Services’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$864K Buy
8,912
+5,243
+143% +$509K 0.06% 163
2025
Q3
$361K Buy
3,669
+224
+7% +$20.6K 0.03% 278
2025
Q2
$308K Sell
3,445
-257
-7% -$21.8K 0.03% 300
2025
Q1
$306K Sell
3,702
-121
-3% -$10.8K 0.03% 280
2024
Q4
$308K Buy
3,823
+21
+0.6% +$1.82K 0.03% 288
2024
Q3
$334K Buy
3,802
+360
+10% +$30.3K 0.03% 269
2024
Q2
$265K Buy
3,442
+498
+17% +$40.8K 0.03% 300
2024
Q1
$247K Buy
+2,944
New +$251K 0.03% 306
2023
Q4
Sell
-3,773
Closed -$288K 328
2023
Q3
$288K Buy
3,773
+317
+9% +$26.5K 0.03% 233
2023
Q2
$297K Buy
3,456
+562
+19% +$48.4K 0.03% 229
2023
Q1
$232K Buy
2,894
+253
+10% +$20.6K 0.03% 254
2022
Q4
$212K Buy
+2,641
New +$214K 0.03% 224
2021
Q4
Sell
-1,619
Closed -$203K 218
2021
Q3
$203K Buy
+1,619
New +$210K 0.03% 194
2020
Q3
Sell
-3,940
Closed -$361K 200
2020
Q2
$361K Buy
3,940
+644
+20% +$61.8K 0.06% 135
2020
Q1
$297K Buy
+3,296
New +$351K 0.05% 141

Other funds holding MDT

Nicolet Advisory Services's MDT Position: Q4 2025 in Review

Nicolet Advisory Services increased its Medtronic (MDT) stake by 143% in Q4 2025, buying an estimated $509K and bringing the position to 8,912 shares worth $864K. The position accounts for 0.06% of the portfolio, ranked #163.

Nicolet Advisory Services first reported a position in MDT in Q1 2020 and has held it in 15 quarters since. 2,303 funds tracked by Wall St. Rank hold MDT as of Q4 2025.

  • Nicolet Advisory Services held 8,912 shares of Medtronic worth $864K as of Q4 2025.
  • Nicolet Advisory Services bought 5,243 Medtronic shares in Q4 2025, an estimated $509K.
  • Medtronic made up 0.06% of Nicolet Advisory Services's portfolio in Q4 2025, its #163 holding.
  • Nicolet Advisory Services first reported a position in Medtronic in Q1 2020 and has held it in 15 quarters since.
  • 2,303 funds tracked by Wall St. Rank held Medtronic as of Q4 2025.

Based on Nicolet Advisory Services's 13F filing for Q4 2025, filed 13 Feb 2026.